Reduced-dose nanoparticle albumin-bound-paclitaxel combined with ramucirumab as second-line treatment for advanced gastric cancer: a multicenter phase II study.
Overview & Synopsis
Open access biomedical research article published in BMC Cancer.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Reduced-dose nanoparticle albumin-bound-paclitaxel combined with ramucirumab as second-line treatment for advanced gastric cancer: a multicenter phase II study. |
|---|---|
| Author / Organization | Iida M, Nakashima C, Kawaoka T, Kondo J, Yamamoto T, Yoshino S, Tokuno K, Kuga T, Dairaku K, Nakagami Y, Watanabe Y, Matsui H, Shindo Y, Takahashi H, Ioka T, Nagano H |
| Subject & Discipline | BMC Cancer |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-35188 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |